Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 66 of 66 entries
View as:

Bioequivalence Study Between Tasimelteon Capsule Formulation and Liquid Suspension Formulation in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT05572281 Org: User:
Start: 05/18/22 End: 06/15/22 Due: 06/15/23

A Study to Evaluate Iloperidone for the Treatment of Parkinson's Disease Psychosis

Phase: N/A Priority: Normal
NCT ID: NCT05344365 Org: User:
Start: 06/30/22 End: 11/30/23 Due: 11/30/24

Pharmacokinetics of Tasimelteon Alone and in Combination With a CYP3A4 Inhibitor, Ketoconazole, or a CYP3A4 Inducer, Rifampin.

Phase: N/A Priority: Normal
NCT ID: NCT01637636 Org: User:
Start: 06/30/12 End: 08/31/12 Due: 08/31/13

Pharmacokinetics of Tasimelteon Alone and in Combination With CYP1A2 Inhibitor, Fluvoxamine

Phase: N/A Priority: Normal
NCT ID: NCT01540500 Org: User:
Start: 02/29/12 End: 03/31/12 Due: 03/31/13

Open Label Safety Study of Tradipitant in Idiopathic and Diabetic Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT06836557 Org: User:
Start: 01/09/24 End: 12/31/25 Due: 12/31/26

Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant

Phase: N/A Priority: Normal
NCT ID: NCT06701396 Org: User:
Start: 10/08/24 End: 06/30/25 Due: 06/30/26

Motion Syros: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Phase: N/A Priority: Normal
NCT ID: NCT04327661 Org: User:
Start: 11/15/21 End: 04/12/23 Due: 04/12/24

Evaluating the Effects of Tradipitant vs. Placebo in Atopic Dermatitis (EPIONE2)

Phase: N/A Priority: Normal
NCT ID: NCT04140695 Org: User:
Start: 10/21/19 End: 10/14/20 Due: 10/14/21

Motion Serifos: A Study to Investigate the Efficacy of Tradipitant in Participants Affected by Motion Sickness

Phase: N/A Priority: Normal
NCT ID: NCT05903924 Org: User:
Start: 09/09/23 End: 04/24/24 Due: 04/24/25

Tradipitant in Treatment-resistant Pruritus Associated With Atopic Dermatitis

Phase: N/A Priority: Normal
NCT ID: NCT02651714 Org: User:
Start: 01/19/16 End: 08/04/17 Due: 08/04/18

Motion Sifnos: A Study to Investigate the Efficacy of Tradipitant in Subjects Affected by Motion Sickness

Phase: N/A Priority: Normal
NCT ID: NCT03772340 Org: User:
Start: 12/20/18 End: 06/27/19 Due: 06/27/20

Evaluating the Effects of Tasimelteon vs Placebo on Sleep Disturbances in SMS

Phase: N/A Priority: Normal
NCT ID: NCT02231008 Org: User:
Start: 09/30/15 End: 01/31/22 Due: 01/31/23

Study of Itch Control by VLY-686 in Healthy Volunteers After Intradermal Injections of Substance P

Phase: N/A Priority: Normal
NCT ID: NCT01919944 Org: User:
Start: 08/31/13 End: 11/30/13 Due: 11/30/14

Single-Patient Expanded Access Protocol for Tradipitant In A Single Patient With Gastroparesis

Phase: N/A Priority: Normal
NCT ID: NCT04474990 Org: User:
Start: - End: - Due: -

Pharmacokinetics of Tasimelteon in Subjects With Renal Impairment and Matched Control Subjects With Relatively Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT01526746 Org: User:
Start: 02/29/12 End: 06/30/12 Due: 06/30/13

Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder

Phase: N/A Priority: Normal
NCT ID: NCT06830044 Org: User:
Start: 03/03/25 End: 03/31/28 Due: 03/31/29